Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albutein 20% in decompensated cirrhosis with ascites
NCT03451292Phase 3Completed
- Sponsor
- Grifols
- Start
- Jul 2018
- Primary completion
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
Phase 3, randomised, open-label trial of human albumin in decompensated cirrhosis and ascites, sponsored by Grifols. Primary endpoint: Time to Liver Transplantation or Death Through 1 Year After Randomization. Started Jul 2018; status: completed.
02
Drugs
human albumin
03
Conditions
decompensated cirrhosisascites
Beyond the preview
Go deeper on NCT03451292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451292.